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A report on the Fourth Annual HUPO World Congress
(HUPO 2005) ‘From Defining the Proteome to
Understanding Function’, Munich, Germany, 28 August-
1 September 2005.
At this year’s annual congress of the Human Proteome Orga-
nization (HUPO) in Munich, some 2,100 scientists and rep-
resentatives from industry discussed recent innovations,
developments and state-of-the-art techniques in proteomics.
Preceding the main meeting, a day of review lectures also
provided an excellent preparation for students and newcom-
ers to the field. This report discusses a few of the highlights
of the meeting. 
The integration of data from the various ‘-omics’ fields and
putting the parts into a cohesive whole are important steps
towards a systems-biology approach, as pointed out by the
President of the German Research Foundation Ernst-Ludwig
Winnacker (University of Munich, Germany). Along similar
lines, Sam Hanash (Fred Hutchinson Cancer Research
Center, Seattle, USA) emphasized in his talk on HUPO ini-
tiatives that contrary to widespread opinion, collaboration
between industry and academia in proteomics is indeed fea-
sible, despite the heterogeneity of the technology used and
the complexity of the science. There had been many suc-
cesses, he noted, for example, progress in the description of
the proteomes of specific organs, organ systems and cell
types, the production of usable and validated antibodies for
any human protein, and access to type-specific subpro-
teomes such as the phosphoproteome (phosphorylated pro-
teins), the glycoproteome (glycoproteins), the secretome
(secreted proteins) and others.
Antibodies are widely used in proteomics for protein detection
and identification in immunohistological studies, protein
arrays, affinity separation techniques, in vivo analysis, and so
on. Matthias Uhlen (Royal Institute of Technology, Stockholm,
Sweden) underlined the importance of properly validated
antibodies of proven quality with known monospecific
epitope-binding sites for the accurate analysis of proteins in
cells and tissues in healthy people and cancer patients. The
targets of nearly 90% of all known pharmaceuticals are
proteins, and the highlight of Uhlen’s talk was the release
and online demonstration of the Human Protein Atlas
[http://www.hpr.se/] for normal and diseased tissue, a web-
based repository of histological micrographs showing the
distributions of a variety of protein types and species in their
cellular environment. 
Proteomics and the clinic
Denis Hochstrasser (University of Geneva, Switzerland)
focused on the application of proteomics in the clinical
environment. He especially considered the problems
encountered in sample conservation and in immediate sample
preparation while still at the patient’s bedside. Several research
studies that should guarantee an unchanged sample were
discussed, for example the use of sugars containing buffers and
sugar alcohols as antifreeze agents - as used by many animals
to prevent freezing in winter. Hochstrasser noted that to
simplify handling, protein samples can be digested by trypsin
immediately after sampling and the peptide fragments
separated by isoelectric focusing (IEF). Because of its high
resolving power compared to chromatographic techniques, IEF
is often the first step in sample preparation for protein identifi-
cation by mass spectrometry (MS). Applying his techniques
Hochstrasser was able to show in studies on the human brain
proteome that there are strong overlaps in the proteome
signatures of stroke and Alzheimer’s disease patients. Jan van
Oostrum (Novartis Institutes for BioMedical Research, Basel,
Switzerland) described how proteomic results can help in
understanding the principles underlying myopia (shortsighted-
ness), in which a longer eyeball leads to imperfect focusing of
light on the retina. Working on the chicken, van Oostrum and
his colleagues have been able to show that Apo A1 may be
associated with longitudinal growth of the eyeball. Organizing the data
Peer Bork (European Molecular Biology Laboratory, Heidel-
berg, Germany) presented computational tools such as
SMART for determining homology-based protein structure
and STRING for protein-association-network analysis. He
also discussed how the correlation of protein-expression
data, cell-cycle stage and cellular compartment should give
insights into the function of a protein in the cell. Bork
showed clearly that only the combination of both techniques
- homology and network-based protein analysis - coupled
with interaction studies and other experimental techniques
can give scientific conclusions on the function of still-
unknown proteins. At the metagenomics level, Bork
described recent work that determined the distribution of
genes in microbial communities. As well as discovering new
unculturable species, the metagenomic approach can also
reveal metabolic fluxes and networks in ecological niches.
The meeting also included informal discussions and ‘surgeries’
to address particular problems. At the bioinformatics
surgery, representatives from academia and industry con-
tinued their efforts to develop standards for proteomics
experiments and data. Discussions at the HUPO 2002
meeting have already resulted in several standard
requirements for proteomics data presentation, such as
MIAPE (the minimum reporting requirement for a proteomics
experiment) [http://psidev.sourceforge.net] a subset of the
experimental results that contains enough information to
assess the provenance and relevance of the methods, results
and conclusions. Another standard format is mzXML, a
mark-up language for online presentation of MS data. The
purpose of the data formats is to establish standards for
sample definition, separation techniques (gels, chromato-
graphy) and MS data-based identification and characterization
of proteins or peptides, that means all data necessary for the
reproduction, verification, comparison and exchange of
experiments. It was emphasized that an objective review of
new publications from the proteomics field without any
access to the underlying data is almost impossible. For this
reason the construction of a public repository of proteomics
data where all published results and especially the corre-
sponding raw data should be stored according to the agreed
standards was discussed. Because DNA-sequence databases
and gene-expression experiment repositories are highly
accepted amongst scientists this aim is a logical consequence
of the rapid development of proteomics techniques during
the last few years. Hopefully these efforts will generate final
results in the near future.
In the MS age of proteomics especially, it is obvious that
intensively maintained databases are a key resource for
high-quality protein identification. Amos Bairoch (Swiss
Institute of Bioinformatics, Geneva, Switzerland) presented
plans for improving UniProt [http://www.pir.uniprot.org/],
one of the best annotated databases for protein sequences,
with respect to protein variations caused by single-nucleotide
polymorphisms  (SNPs), single amino-acid polymorphisms,
splice variants and other post-transcriptional modifications.
This repository of protein data will probably become a highly
qualitative tool for doing proteomic studies.
Proteomics technologies
Several major milestones in the development of proteomics
were reviewed at the meeting. Patrick O’Farrell (University
of California, San Francisco, USA) looked back at his post-
graduate studies, during which he invented a technique that
reviewers at the time thought not worth publishing - two-
dimensional gel electrophoresis. Nobel laureate John Fenn
(Commonwealth University, Richmond, USA) presented his
remarkable work developing electrospray ionization for MS.
He was followed by Franz Hillenkamp (University of Münster,
Germany) who presented past, present and future aspects of
matrix-assisted laser desorption ionization (MALDI)-MS in
proteomics and how to bring the matrix in closest contact to
the sample to enforce the best possible ionization.
Moving on to more recent developments, John Yates (Scripps
Research Institute, La Jolla, USA) discussed a shotgun
approach for total proteome analysis modeled on the
genomic shotgun. All the proteins in the sample are cleaved
by different proteases and as many peptide fragments as pos-
sible from the mixture are captured and characterized by MS.
Angelika Görg (Technical University of Munich, Germany),
who pioneered the development of immobilized pH gradients
for protein separation, astonished the audience with her
extremely simple and convenient protein prefractionation
technique using isoelectric focusing (IEF) trays filled with
Sephadex. This allows exceptionally large amounts of proteins
or protein extracts to be separated over a wide pH gradient,
and because Sephadex is very easy to handle, it is simple to
reseparate the defined pI fractions on normal immobilized
pH gradient (IPG) strips with reults of amazing quality. 
Because of the importance of new liquid chromatography (LC)
techniques for the separation and fractionation of complex
peptide mixtures, a talk by Petra Olivova (Waters Corporation,
Milford, USA) compared several two-dimensional lipid chro-
matography techniques; to measure the efficiency of two-
dimensional separation, an orthogonality index was
introduced. Also in this context, Joël Vandekerckhove (Uni-
versity of Ghent, Belgium) described the technique of com-
bined fractional diagonal chromatography (CoFraDiC), an
application of liquid chromatography. This technique enables
the n-dimensional separation of peptide mixtures by one type
of chromatography as a result of the peptide-modifying steps
inserted between each liquid chromatography run.
One trend that emerged from the meeting was the automation,
parallelization (for example, multiple electrospray ionization
sources in one MS device) and miniaturization of gel-free tech-
niques for computer-aided analysis. Physiological proteomics
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two-dimensional gel electrophoresis can now be addressed
with gel-free techniques. Stable isotope labeling of proteins
followed by LC-MS separation enables the analysis of
protein  synthesis or protein modifications in response to
stimuli (such as abiotic stimuli, drugs, and disease) by gel-free
techniques. An advance in the measurement of absolute
protein amounts was described by Yasushi Ishihama (Eisai
Company, Tsukuba, Japan), who described techniques for
comparing an isotope-coded peptide population with
uncoded peptides from the cell extract of interest. Despite
these advances, it was clear from several presentations that the
standard two-dimensional-gel analysis approach can still be
improved by new image-processing techniques to give much
more reliable data. 
Biological applications
The application of gel-based proteomics in bacterial pro-
teomics was described by Michael Hecker (Ernst-Moritz-
Arndt-University, Greifswald, Germany), whose talk
included topics ranging from descriptive bacterial pro-
teomics, including the identification of proteins and their
modifications and localizations, to an understanding of bac-
terial physiology in the model organism Bacillus subtilis.
The newly developed paradigms in image analysis, repre-
sented by the Delta2D software Hecker used, enabled the
most reliable data acquisition as well as impressive data
visualization using color-coded proteome maps. The soft-
ware uses a fusion gel from all images that are to be ana-
lyzed. On this fusion image (the proteome map) spots are
detected and their boundaries used for the quantitation of
each single gel, resulting in 100% accurate spot matching. 
Erin O’Shea (Harvard University, Cambridge, USA) brought
aspects of protein expression, abundance and stability into
focus in her talk on yeast physiology, which included an
impressive systematic analysis of extremely large amounts of
data. The consequences of protein stability, fold-change of
mRNA expression and mRNA stability on protein abun-
dance were discussed. O’Shea provided an insight into how a
small unicellular organism regulates gene expression not
only at the level of transcriptional activation but also at the
level of mRNA processing and posttranscriptionally at the
protein level. She showed, for example, that especially stable
proteins are highly regulated at the level of mRNA produc-
tion and degradation.
Pier Righetti (University of Verona, Italy) closed the con-
gress with a talk on “the democratic proteome”. According to
Righetti “mining below the tip of the iceberg for detecting
the unseen proteome” is becoming feasible as emerging
technologies allow the detection of low-abundance proteins.
He demonstrated the use of so-called ‘protein equalizer
beads’ with combinatorial variable acceptor specificity for
capturing proteins from a solution. This technique was
derived from affinity chips. Protein equalizer beads, which
bind proteins using ligand libraries, are extremely useful for
removing high-abundance proteins from serum or other
body fluids to reveal the low-abundance proteins. Equalizer
beads can also be used for the quality control of prepurified
proteins. In this case, the main component protein can be
removed and the remaining contaminants can be analyzed. 
The HUPO 2005 meeting clearly shows that, after having gone
a long way towards manufacturing its own tools and developing
standards, the proteome community is returning to life
science-related problems. This is absolutely essential for the
community to be prepared for the next stage: systems biology. 
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